Gene therapy offers hope for cystic fibrosis patients
3 July 2015 | By Victoria White
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial...
List view / Grid view
News
UK leads Europe in antimicrobial point-of-care diagnostics research
2 July 2015 | By Victoria White
The UK takes the lead position when it comes to patent filings for antimicrobial point-of-care diagnostics in Europe...
Novo Nordisk to cease distribution of Tresiba in Germany
2 July 2015 | By Victoria White
Novo Nordisk has decided to cease distribution of its once-daily basal insulin Tresiba (insulin degludec) in Germany...
AbbVie to expand its medical device manufacturing facility in Ballytivnan
2 July 2015 | By Victoria White
AbbVie is to further expand its medical device manufacturing facility in Ballytivnan, Sligo, Ireland, and create 50 new highly-skilled jobs...
Recent drug approvals will boost Parkinson’s disease therapeutics market
2 July 2015 | By Victoria White
The Parkinson’s disease treatment market value across eight major countries will reach $4.7 billion by 2022, says GlobalData...
Gilead submits NDA for single tablet regimen for HIV containing rilpivirine, emtricitabine and tenofovir alafenamide (R/F/TAF)
2 July 2015 | By Victoria White
Gilead Sciences has submitted a NDA to the FDA for an investigational, once-daily single tablet regimen for the treatment of HIV-1 infection...
Sartorius Stedim Biotech acquires Cellca
Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014.
Sembragiline fails to meet primary endpoint in Phase IIb trial in Alzheimer’s disease
2 July 2015 | By Victoria White
Evotec and Roche have provided an update on the initial results of the Phase IIb trial with Sembragiline for the treatment of Alzheimer's disease...
Teva’s DuoResp Spiromax wins silver at the 2015 Medical Design Excellence Awards
2 July 2015 | By Victoria White
Teva’s DuoResp Spiromax inhaler for patients with asthma and COPD has won silver at the 2015 Medical Design Excellence Awards (MDEA)...
UK government intends to publish cost of NHS drugs to shame patients
2 July 2015 | By Victoria White
Jeremy Hunt has called for a new social contract between the public, health and care services, and has urged the public to take more personal responsibility...
COPD maintenance treatment, Spiolto Respimat, approved in first European countries
2 July 2015 | By Victoria White
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in a number of European countries...
10th annual Cold Chain Distribution Conference and Exhibition
1 July 2015 | By
This year’s Cold Chain Distribution is the must attend event providing hours of networking with your peers, where you will hear case studies, presentations and round table discussions on the key issues...
Registration now open for the 10th annual Cold Chain Distribution Conference and Exhibition
1 July 2015 | By SMi Group
SMi Group reports registration is now live for the 10th annual Cold Chain Distribution Conference and Exhibition on 3rd – 4th December at the Victoria Park Plaza Hotel in London, UK...
Teva and Xenon provide update on TV-45070 Phase 2b study in osteoarthritis pain
1 July 2015 | By Victoria White
Teva and Xenon have reported top line results from a Phase 2b study designed to evaluate the safety and efficacy of TV-45070 in patients with osteoarthritis...
CPhI makes it easy for pharma to implement charity into CSR strategy
1 July 2015 | By Victoria White
CPhI Worldwide is calling on all its attendees, exhibitors and the wider pharma community to help it in its latest project with CPhI Angels...
